ALZN CIK: 1677077

Alzamend Neuro, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY22 to FY26
millions USD
FY22:
−6.61
FY23:
−8.92
FY24:
−8.27
FY25:
−6.57
FY26:
−8.07
Change from FY22 to FY25
millions USD
FY22:
−0.11
FY23:
–
FY24:
−0.15
FY25:
−0.30
FY26:
–
Change from FY22 to FY26
millions USD
FY22:
18.9
FY23:
0.00
FY24:
3.65
FY25:
10.4
FY26:
4.83
(positive)
Change from FY22 to FY26
millions USD
FY22:
−6.72
FY23:
–
FY24:
−8.42
FY25:
−6.87
FY26:
−8.07

All amounts in millions USD Data sources:SEC EDGARTwelve Data